Sign up to get updates from us
If the pandemic taught us nothings else, we’ve learned the critical importance of having a dependable system for delivery. OncoNano offers two such systems (read: platforms). The first, ON-BOARD, is a polymeric micelle that delivers its therapeutic payload only in the acidic environment of a tumor bed. The second, OMNI, consists of a polymer that in itself stimulates the immune-activating STING pathway, and which can further be loaded with other STING agonists, or, potentially, other mechanistically relevant oncology agents. POC phase II trials are underway…
